Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Randomized Placebo-controlled Trial
100%
Depressive Disorder
100%
Mirtazapine
100%
Post-myocardial Infarction
100%
Antidepressants
50%
Symptom Checklist-90 (SCL-90)
50%
Beck Depression inventory-II (BDI-II)
50%
Placebo
33%
Antidepressant Efficacy
33%
Hamilton Depression Rating Scale (HAM-D)
33%
Last Observation Carried Forward
33%
Clinical Global Impression Scale
33%
Placebo-controlled
16%
Randomized Double-blind
16%
Major Depressive Disorder
16%
First Year
16%
Depressive Symptoms
16%
Myocardial Infarction
16%
Selective Serotonin Reuptake Inhibitors
16%
Repeated Measures Analysis
16%
Statistical Manual of Mental Disorders
16%
Multicenter Cohort Study
16%
Depression Score
16%
Mixed Model Analysis
16%
Mixed Model Approach
16%
DSM-IV
16%
Clinical Global Impression
16%
17-item Hamilton Depression Rating Scale
16%
4th Edition
16%
Double-blind Placebo-controlled Trial
16%
Dual-acting
16%
Secondary Depression
16%
Acute Treatment Phase
16%
Forward Procedure
16%
Forward Method
16%
Minor Depressive Disorder
16%
Neuroscience
Placebo
100%
Myocardial Infarction
100%
Mirtazapine
100%
Depressive Disorder
100%
Antidepressant
83%
Beck Depression Inventory
50%
Symptom Checklist 90
50%
Hamilton Rating Scale for Depression
50%
Major Depressive Disorder
16%
Minor Depression
16%
Selective Serotonin Reuptake Inhibitor
16%
Diagnostic and Statistical Manual of Mental Disorders
16%